Weight-loss drug startup Metsera wants to take on Novo and Lilly. Here’s what you need to know
Fast CompanyMetsera, a clinical-stage biotechnology startup that develops drugs for obesity and metabolic diseases, launched on Thursday with what it described as a “broad portfolio” of weight-loss treatments that it hopes to bring to market.
The c…